NewsRoom Articles - Page 40 of 229

WednesdayDec 04, 2024 9:30 am

Astiva Health Inc. Expecting to Build Upon This Year’s Performance with Significant Membership Boost in 2025

The company anticipates a 70% increase in membership in the upcoming year, growing the current number of members from 13,000 in June 2024 to 20,000 in 2025. The fourfold increase in membership reflects the growing demand for a change in approach to healthcare that combines innovative personalized strategies with a deep understanding of the served communities. The company has established a strong network of over 12,940 providers, enabling it to offer comprehensive care to its rapidly growing member base, especially in Southern California. Astiva Health, a fast-growing Medicare Advantage Prescription Drug (“MAPD”) health plan, dedicated to reshaping personalized and comprehensive…

TuesdayDec 03, 2024 2:30 pm

Adageis Is ‘One to Watch’

Adageis operates in the rapidly expanding AI healthcare market, projected by Fortune Business Insights to reach $490.96 billion by 2032. The ProActive Care Platform offers seamless integration with existing EMR systems, reducing adoption barriers for healthcare providers. Partnerships with prominent organizations, such as HealthyU Clinics, and its status as an AthenaHealth marketplace partner, demonstrate Adageis’ growing influence in the healthcare sector. The company’s AI-driven predictive analytics enhance patient care and operational efficiency, aligning with the industry’s shift toward value-based care models. Led by a seasoned leadership team with extensive experience in healthcare and technology, Adageis is well-equipped to navigate the evolving healthcare…

TuesdayDec 03, 2024 10:00 am

e-Commerce Sees New Record as Thanksgiving Shoppers Go All Out on Spending

2024 saw Thanksgiving sales increase, with mobile and e-commerce purchases hitting new highs. An analysis conducted by Adobe Analytics determined that by the end of November 28th, online consumers had spent $6.1 billion during Thanksgiving. This figure represents an 8.8% increase from 2023’s Thanksgiving sales. Adobe Digital Insights’ lead analyst Vivek Pandya stated that Cyber Week had started on a strong high, with huge discounts driving impulse shopping in categories like apparel and electronics. Cyber Week refers to the 5-day period which includes Thanksgiving, Black Friday and Cyber Monday. This year, Cyber Monday was on December 2nd. Salesforce, an e-commerce…

TuesdayDec 03, 2024 8:00 am

Annovis Bio Inc. (NYSE: ANVS) to Present Recent Achievements and 2025 Strategic Outlook During Upcoming Live Investor Webcast

The webcast led by Annovis’ Founder, President and CEO, Maria Maccecchini, Ph.D., will take place on Dec. 11, at 4:30 p.m. EST. Dr. Maccecchini will provide a comprehensive view of the company’s recent achievements along with strategic initiatives for 2025, followed by a Q&A session. The company recently received FDA clearance to proceed with a pivotal Phase 3 Alzheimer’s disease program for lead drug candidate buntanetap, set to begin in early 2025. Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), will hold a…

MondayDec 02, 2024 10:00 am

AI Model Promises New Way to Detect Brain Malignancies

Central nervous system and brain cancers accounted for 248,500 deaths globally in 2022. In America, roughly 90,000 brain tumors are diagnosed annually, with data from the American Cancer Society showing that over 25,000 of these tumors are cancerous. It is projected that there’ll be an estimated 25,400 new cases of central nervous system and brain cancers in 2024. Estimates also show that roughly one million individuals in the U.S. live with a primary brain tumor, with about 28% of all brain tumors being malignant. Glioblastoma, a fatal form of brain cancer, accounts for 50% of all malignant brain tumors in…

TuesdayNov 26, 2024 10:00 am

MS Drug Could Counter Poor Working Memory

A new study has determined that a medication normally prescribed for multiple sclerosis can help persons with poor working memory. Working memory is an important component of cognitive function. Sadly, it is often impaired in patients with conditions like schizophrenia. The study was led by University of Basel’s Professors Dominique de Quervain and Andreas Papassotiropoulos. For their randomized and double-blind study, the researchers tested the efficacy of fampridine on the working memory of forty-three healthy adults. Fampridine, the medication in question, is normally used to enhance walking ability for patients with multiple sclerosis. Patients with this chronic illness often experience…

MondayNov 25, 2024 8:45 am

Kairos Pharma Ltd. (NYSE: KAPA) Developing Innovative Therapies to Tackle Cancer Drug Resistance, Immune Suppression

The company has an extensive IP portfolio, valid through 2040, and a drug pipeline in different preclinical and clinical stages, targeting cancer drug resistance and immune suppression. Kairos Pharma’s lead candidate ENV-105 is an antibody targeting CD105, a protein identified as a key driver of resistance to various cancer treatments. ENV-105 is in a Phase 2 trial for castrate-resistant prostate cancer (NCT05534646, in combination with Apalutamide) and a Phase 1 trial for EGFR-driven non-small cell lung cancer (NCT05401110, in combination with Osimertinib). The company is working with PreCheck Health Services to develop companion biomarkers for ENV-105, with the aim of…

FridayNov 22, 2024 10:00 am

Could a Medicare Special Needs Plan Be Right for You?

A Special Needs Plan (SNP) customizes medical benefits for individuals who have chronic illnesses, are on Medicaid, or live in specific institutions. SNPs are offered under Medicare Advantage, with figures showing that enrollees under this plan may hit 28% by next year. What should you know about SNPs? They cover hospital care (Part A), physician visits and some other charges (Part B) and prescription drugs (Part D). There are three kinds of SNPs; Chronic condition SNPs These plans cover patients with disabling or severe chronic diseases like diabetes, stroke, chronic heart failure, and cancer. Dual-eligible SNPs This covers individuals eligible…

FridayNov 22, 2024 8:00 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Shares Data Supporting Innovative Proprietary Systemic Antitumor Platform

“In 2024, over 611,000 deaths from cancer are projected for the U.S.,” the ACA reported. “That’s more than 1,600 deaths from cancer each day.” Calidi Biotherapeutics’ RTNova (“CLD-400”) is an innovative systemic antitumor enveloped virotherapy, designed to unlock new possibilities in cancer therapy. RTNova offers a systemic approach that enables providers to target and treat metastatic tumors that were previously untouchable. The American Cancer Society (“ACA”) has projected that 2024 will be the first year ever to see two million people diagnosed with cancer, which remains the second leading cause of death in the United States, after heart disease (https://ibn.fm/ADo2Q).…

ThursdayNov 21, 2024 10:00 am

Research Suggests Cancer Survivors are Less Prone to Alzheimer’s Development

Alzheimer’s and cancer are common diagnoses, especially among older individuals. Prior research has observed an inverse association between both conditions, with a separate study also finding that survivors of cancer have a lower risk of developing Alzheimer’s in comparison to individuals without a history of cancer. Now new research has uncovered evidence of a lower prevalence of dementia following a patient’s cancer diagnosis. The research was carried out by scientists at Imperial College, who focused on health data of over three million individuals aged 60 and above. The scientists performed genetic analyzes on hundreds of genes, finding a genetic profile…